You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

List of Excipients in API penciclovir


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing penciclovir

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 CETOSTEARYL ALCOHOL
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 MINERAL OIL
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 PETROLATUM
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 POLYOXYL 20 CETOSTEARYL ETHER
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 PROPYLENE GLYCOL
Mylan Pharmaceuticals Inc PENCICLOVIR penciclovir 0378-0896 WATER
Mylan Pharmaceuticals Inc DENAVIR penciclovir 0378-9720 CETOSTEARYL ALCOHOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing penciclovir

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 CETOSTEARYL ALCOHOL
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 MINERAL OIL
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 POLYOXYL 20 CETOSTEARYL ETHER
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 PROPYLENE GLYCOL
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 WATER
Teva Pharmaceuticals USA Inc penciclovir 0093-3186 WHITE PETROLATUM
Torrent Pharmaceuticals Limited penciclovir 13668-661 CETOSTEARYL ALCOHOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for penciclovir

Excipient focus: CETETH-20

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: MINERAL OIL

Excipient focus: PETROLATUM

Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER

Excipient focus: PROPYLENE GLYCOL

Excipient focus: WATER

Excipient focus: WHITE PETROLATUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group